spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online 16 August 2005
doi: 10.1242/jcs.02518


Journal of Cell Science 118, 3949-3958 (2005)
Published by The Company of Biologists 2005
This Article
Right arrow Summary Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Urbinati, C.
Right arrow Articles by Rusnati, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Urbinati, C.
Right arrow Articles by Rusnati, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

{alpha}vß3-integrin-dependent activation of focal adhesion kinase mediates NF-{kappa}B activation and motogenic activity by HIV-1 Tat in endothelial cells

Chiara Urbinati1, Antonella Bugatti1, Mauro Giacca2, David Schlaepfer3, Marco Presta1 and Marco Rusnati1,*

1 General Pathology and Immunology, Department of Biomedical Sciences and Biotechnology, School of Medicine, University of Brescia, viale Europe 11, 25123 Brescia, Italy
2 International Center for Genetic Engineering and Biotechnology, Padriciano 99, 34012 Trieste, Italy
3 The Scripps Research Institute, Department of Immunology, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA



View larger version (25K):

[in a new window]
 
Fig. 1. Cell-free interaction of Tat with {alpha}vß3 integrin. (A) Aliquots of purified human {alpha}vß3 were incubated on plastic coated with BSA, FN, GST or GST-Tat. At the end of incubation, plastic-bound proteins were extracted and analysed by western blotting with anti-ß3 antibodies. (B) Purified {alpha}vß3 was injected at (from top to bottom) 100, 50, 25, 18, 15, 10, and 5 nM for 4 minutes over a BIAcore sensorchip coated with GST-Tat. (C) {alpha}vß3 (100 nM) or the buffer alone were injected over BIAcore sensorchips coated with GST-Tat or BSA. In all the experiments the responses (in RU) were recorded as a function of time.

 


View larger version (33K):

[in a new window]
 
Fig. 2. Immobilized Tat promotes adhesion and motogenic activity in ECs. (A) GM7373 cells were allowed to adhere to plastic coated with the indicated concentrations of native GST-Tat (), GST ({triangledown}), FN ({blacksquare}) or BSA ({triangleup}). (B) GM7373 cells were incubated for 1 hour at 4°C with the indicated concentrations of anti-{alpha}vß3 neutralizing monoclonal antibody LM 609 (closed symbols) or irrelevant IgG (open symbols). Then, cells were allowed to adhere to plastic coated with 20 µg/ml of GST-Tat (circles) or FN (squares). (C) GM7373 cells were allowed to adhere to plastic coated with 20 µg/ml of native (a) or heat denatured (e) wild-type GST-Tat, GST-Tat{Delta}1-21 (b), GST-TatK49/52/53/55/56/57A (c), GST-Tat-1e (d). (D) HUVE cells or MAE cells were allowed to adhere on plastic coated with 20 µg/ml of GST-Tat (black bars), FN (hatched bars), or BSA (white bars). At the end of incubation, cell adhesion was quantified. In B, data are expressed as the percentage of cells adherent to the different substrata in the absence of antibodies. Each point is the mean ± s.e.m. of three or four determinations in duplicate. (E) GM7373 cell monolayers adherent to the indicate plastic-immobilized proteins or to tissue culture plastic (t.c.p.) were wounded and incubated for 48 hours in culture medium containing 0.4% FCS in the absence (white bars) or in the presence of free GST-Tat (100 ng/ml; black bars), cRGDfV (grey bars) or cRADfV (hatched bars) (both at 3 µM). At the end of incubation the area of the wound was quantified by image analysis. Each point is the mean ± s.e.m. of four to five fields measured in one experiment out of two or three that gave similar results. The results are expressed as percentage of repair in respect to untreated monolayers adherent to immobilized Tat. (F) Representative microphotographs (magnification 50x) of Tat-adherent GM7373 cell monolayers at T0 and 48 hours after the wounding.

 


View larger version (43K):

[in a new window]
 
Fig. 3. FAK, RhoA and pp60src activation by Tat in ECs. (A) GM7373 cells were allowed to adhere to plastic coated with 20 µg/ml of GST-Tat or PL, or were maintained in suspension (s) for 30 minutes. Then, cells were lysed, and analysed for FAK, RhoA or pp60src activation (a, activated/phosphorylated protein; t, total protein). (B,C) GM7373 cells adherent to cell culture plates were incubated for 30 minutes at 37°C with the indicated concentrations of free GST-Tat (B) or with 100 ng/ml of GST-Tat for the indicated periods of time (C). Then, cells were lysed, immunoprecipitated with anti-FAK antibodies and immunoblotted with anti-phosphotyrosine antibody. (D) GM7373 cells adherent to cell culture plates were incubated for 30 minutes at 37°C with 100 ng/ml of GST-Tat, lysed, and immunoblotted with antibodies specific for the indicated FAK phosphotyrosine residues. (E) GM7373 cells adherent to cell culture plates were incubated for 30 minutes at 37°C with or without GST-Tat (100 ng/ml) in the absence or in the presence of anti-{alpha}vß3 (LM 609) or irrelevant (N.I.) antibodies (both at 75 µg/ml) or of cRGDfV and cRADfV peptides (both at 3 µM). Then, cells were lysed and immunoblotted with antibodies specific for FAK phospho-Tyr397 residue. In B, C, E and F, the extent of FAK phosphorylation was quantified by image analysis and expressed as fold increase with respect to basal FAK phosphorylation observed in Tat-untreated cells. The data are representative of two to four independent experiments that gave similar results. (F) MAE cells adherent to cell culture plates were incubated for 30 minutes at 37°C in the absence or in the presence of 100 ng/ml of GST-Tat. Then, cells were lysed, immunoprecipitated with anti-FAK antibodies, and immunoblotted with anti-FAK or anti-phosphotyrosine antibodies. a, phosphorylated protein; t, total protein.

 


View larger version (65K):

[in a new window]
 
Fig. 4. Effect of FRNK overexpression in GM7373 endothelial cells. (A) Parental GM7373 cells or the indicated transfectant clones were grown on tissue culture plates, lysed and immunoblotted with an antibody directed against the C terminus of FAK. (B) The different clones were allowed to adhere to plastic coated with 20 µg/ml of GST-Tat (black bars), FN (hatched bars) or BSA (white bars). At the end of incubation, cell adhesion was quantified. Each point is the mean ± s.e.m. of three determinations in duplicate. (C) Representative images showing parental and FRNK-transfected GM7373 cells adherent to GST-Tat or FN (magnification 100x). (D) The different clones were seeded on cell culture plates, incubated for 30 minutes with or without free GST-Tat (100 ng/ml), and immunoblotted with antibodies specific for FAK phospho-Tyr397 residue. Alternatively, the different clones were allowed to adhere to plates coated with GST-Tat or PL and analysed for RhoA or pp60src activation. No significant differences were found in the total/starting levels of FAK, pp60src or RhoA (data not shown). The data are representative of two to three independent experiments that gave similar results.

 


View larger version (22K):

[in a new window]
 
Fig. 5. NF-{kappa}B activation by Tat in ECs. (A) GM7373 were allowed to adhere to plastic coated with the indicated proteins or maintained in suspension (s) for 30 minutes. (B,C) GM7373 adherent to cell culture plates were incubated for 1 hour at 37°C with the indicated concentrations of free GST-Tat (B), or with 100 ng/ml of GST-Tat for the indicated periods of time (C). (D) GM7373 cells adherent to cell culture plates were incubated for 1 hour at 37°C with 100 ng/ml of GST-Tat in the absence (-) or in the presence of SN50, SN50M (both at 25 µg/ml), cRGDfV, cRADfV (both at 3 µM), exoenzyme C3 (5 µg/ml), PP2 or PP3 (both at 100 µM). (E) The different clones adherent to cell culture plates were incubated for 1 hour with (black bars) or without (hatched bars) GST-Tat (100 ng/ml). At the end of incubation, cells were lysed and the activation of the indicated NF-{kappa}B subunit was evaluated. In D, data are expressed as percentage of NF-{kappa}B activation measured in the absence of any inhibitors. In E, data are expressed as fold increase in respect to basal p50 NF-{kappa}B activation observed in Tat-untreated cells. In A and D each point is the mean ± s.e.m. of three determinations in duplicate; the data in B, C and E are representative of three independent experiments that gave similar results.

 


View larger version (22K):

[in a new window]
 
Fig. 6. Characterization of the motogenic activity induced by immobilized-Tat in adherent ECs. (A) Monolayers of the indicated GM7373 clones adherent to immobilized GST-Tat were wounded and incubated for 24 hours (hatched bars) or 48 hours (black bars) in medium containing 0.4% FCS. (B) Monolayer of parental GM7373 cells adherent to immobilized GST-Tat were incubated for 48 hours in the presence of the indicated inhibitors (same doses as in Fig. 5D). At the end of the incubation period the area of the wound was quantified by image analysis. Each point is the mean ± s.e.m. of four to eight fields measured in one experiment out of three that gave similar results. The results are expressed as percentage repair with respect to untreated monolayers adherent to immobilized Tat.

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




© The Company of Biologists Ltd 2005